Morphine Sulfate

Product NDC: 62559-171
11-digit product format: 625590171
Labeler code: 62559
Product ID: 62559-171_16a27365-2e64-4e8f-b46a-3cc41906872d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Morphine Sulfate
Dosage form: SOLUTION
Route: ORAL
Labeler: ANI Pharmaceuticals, Inc.
Application: ANDA205509
Marketing category: ANDA
Marketing start: 2018-07-09
Marketing end: 2022-07-31
Substance: MORPHINE SULFATE
Active strength: 20 mg/5mL
Pharmacologic classes: Full Opioid Agonists [MoA], Opioid Agonist [EPC]
DEA schedule: CII
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	62559-171		D	Discontinued by firm	2026-08-17
excluded package	package	62559-171	62559-171-01	D	Discontinued by firm	2026-08-17
excluded package	package	62559-171	62559-171-05	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62559-171-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	62559-171-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62559-171-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	62559-171-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62559-171-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	62559-171-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62559-171-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	62559-171-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62559-171-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	62559-171-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62559-171-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	62559-171-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62559-171-05	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	62559-171-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62559-171-05	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	62559-171-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62559-171-05	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	62559-171-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	62559-171-05	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	62559-171-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	62559-171-05	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	62559-171-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	62559-171-05	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	62559-171-01	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A205509-001	MORPHINE SULFATE	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17
A205509-002	MORPHINE SULFATE	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17
A205509-003	MORPHINE SULFATE	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205509-002	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A205509-003	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205509-002	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A205509-003	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205509-002	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A205509-003	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205509-002	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A205509-003	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A205509-002	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A205509-003	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A205509-002	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A205509-003	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A205509-002	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A205509-003	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A205509-002	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A205509-003	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A205509-002	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A205509-003	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A205509-002	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A205509-003	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A205509-002	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A205509-003	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A205509-002	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A205509-003	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A205509-002	MORPHINE SULFATE	20MG/5ML	SOLUTION / ORAL	2018-04-17	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A205509-003	MORPHINE SULFATE	100MG/5ML	SOLUTION / ORAL	2018-04-17	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A205509-001	MORPHINE SULFATE	10MG/5ML	SOLUTION / ORAL	2018-04-17	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A205509-001	AA	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A205509-002	AA	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A205509-003	AA	1	`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	A205509-001	AA	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A205509-002	AA	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A205509-003	AA	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A205509-001	AA	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A205509-002	AA	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A205509-003	AA	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A205509-001	AA	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A205509-002	AA	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A205509-003	AA	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A205509-001	AA	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A205509-002	AA	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A205509-003	AA	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A205509-001	AA	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A205509-002	AA	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A205509-003	AA	1	`ea99ee380514…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
62559-171-01	ML - Milliliter	62559-171	cc683777-e495-492a-a59c-81247eafc841	1	2018-08-13
62559-171-05	ML - Milliliter	62559-171	6b7f589a-5002-44b7-bd2e-ade3f33bce60	1	2018-08-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
METOCLOPRAMIDE HYDROCHLORIDE	ACTIVE INGREDIENT	W1792A2RVD	METOCLOPRAMIDE SOLUTION [ANIP ACQUISITION COMPANY]	2
METOCLOPRAMIDE	ACTIVE MOIETY	L4YEB44I46	METOCLOPRAMIDE SOLUTION [ANIP ACQUISITION COMPANY]	2
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	METOCLOPRAMIDE SOLUTION [ANIP ACQUISITION COMPANY]	2
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	METOCLOPRAMIDE SOLUTION [ANIP ACQUISITION COMPANY]	2
FD&C YELLOW NO. 5	INACTIVE INGREDIENT	I753WB2F1M	METOCLOPRAMIDE SOLUTION [ANIP ACQUISITION COMPANY]	2
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	METOCLOPRAMIDE SOLUTION [ANIP ACQUISITION COMPANY]	2
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	METOCLOPRAMIDE SOLUTION [ANIP ACQUISITION COMPANY]	2
SACCHARIN SODIUM DIHYDRATE	INACTIVE INGREDIENT	SB8ZUX40TY	METOCLOPRAMIDE SOLUTION [ANIP ACQUISITION COMPANY]	2
SORBITOL	INACTIVE INGREDIENT	506T60A25R	METOCLOPRAMIDE SOLUTION [ANIP ACQUISITION COMPANY]	2
WATER	INACTIVE INGREDIENT	059QF0KO0R	METOCLOPRAMIDE SOLUTION [ANIP ACQUISITION COMPANY]	2

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X3P646A2J0	MORPHINE SULFATE	6211-15-0	MORPHINE SULFATE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
62559-171-01	62559017101	100 mL in 1 BOTTLE (62559-171-01)	100 ml	2018-07-09	2021-08-31	No	No	Current
62559-171-05	62559017105	500 mL in 1 BOTTLE (62559-171-05)	500 ml	2018-07-09	2022-02-28	No	No	Current